The slip
PARKINSON RECEIPTno. 7628
23 Oct 2026, 14:30 UTCdopamine neurons, braak
predictionC1R in dopamine neurons tracks Braak Lewy-body stage
registered981062c081d63640
discovery-0.38 p=0.309 n=9
replication-0.51 p=0.165 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.38, p 0.309)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT4a623f9b8d8a131ec46223de…
follows 13b8300c8807…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7628: C1R in dopamine neurons, braak
- power
- full sample -0.43 (p 0.072, n 18), 95% CI -0.75 to +0.04. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.39 (p 0.109, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.59 (p 0.010, n 18). not the mix.
- skeptic
- leave-one-out range -0.58 to -0.36, sign flips 0; without severely affected donors -0.43 (p 0.072, n 18). robust.
- cell type
- strongest in oligodendrocytes: -0.59 (p 0.0092, n 18) vs -0.43 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for C1R in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up C1R · oligodendrocytes · braak: substantia nigra, an independent cohort (already registered)